Drug recall · January 6, 2021
Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg recall
Why: Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg, packaged in unit dose packets, Rx only, Manufactured by: Cipla Ltd., Kurkumbh, India, Manufactured for: Cipla USA, Inc. 10 Independence Boulevard, Suite 300 Warren, NJ 07059, NDC 69097-527-34
- Lots / codes
Lot #: KA00411, KA00412, KA00460, Exp 11/2021
- Quantity
- 284,610 packets
- Company
- Cipla, Warren, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- December 17, 2020 · Voluntary: Firm initiated
- Classified
- December 30, 2020
- Reported
- January 6, 2021
- Ended
- December 7, 2022
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Esomeprazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.